MTÜ Psoriaasihaigete Toetamise Ühing
The Support Sociaty for Psoriasis Sufferers in Estonia
Tel. +372 656 7072, 56 204 707, 545 33 660, email: email@example.com
PUVA, UVB, psoriasis and non-melanoma skin cancer
J Am Acad Dermatol. 1993 Dec;29(6):1013-22.
This article reviews the English-language literature on the risk of nonmelanoma skin cancer from phototherapy (UVB) or photochemotherapy (PUVA) in the treatment of psoriasis. The evolution of the debate on the carcinogenic potential of these treatment is discussed, particularly with reference to PUVA. Available data indicate that therapeutic UVB has a low risk of producing cutaneous cancers, with the possible exception of those on male genital skin. However, there is a definite cutaneous carcinogenic risk from oral PUVA. The major associated risk factors are reviewed. We provide recommendations for the assessment and treatment of patients to minimize this risk.
pMID: 8245237 [pubMed - indexed for MEDLINE]
The risk for psoriasis patients on a life long UVB treatment
will probably be of the same order of magnitude as for outdoor workers.
In comparison with other every day risks, the risk of dying from a skin
cancer seems to be negligible. Regular check-ups by a dermatologist can
reduce this risk close to zero.
|MTÜ Psoriaasihaigete Toetamise Ühing, Copyright 2003-2007|
| Kontakt | E-mail
| Psoriaas | valgusraviseadmete
Kirjandus | Artiklid | Otsing| Sisukaart | Lingid | Partnerid